NO20052655D0 - Sammensmeltede heterocykliske forbindelser - Google Patents
Sammensmeltede heterocykliske forbindelserInfo
- Publication number
- NO20052655D0 NO20052655D0 NO20052655A NO20052655A NO20052655D0 NO 20052655 D0 NO20052655 D0 NO 20052655D0 NO 20052655 A NO20052655 A NO 20052655A NO 20052655 A NO20052655 A NO 20052655A NO 20052655 D0 NO20052655 D0 NO 20052655D0
- Authority
- NO
- Norway
- Prior art keywords
- merged
- heterocyclic compounds
- heterocyclic
- compounds
- merged heterocyclic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US42445602P | 2002-11-06 | 2002-11-06 | |
PCT/US2003/035543 WO2004043958A1 (en) | 2002-11-06 | 2003-11-06 | Fused heterocyclic compounds |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20052655D0 true NO20052655D0 (no) | 2005-06-02 |
NO20052655L NO20052655L (no) | 2005-07-26 |
Family
ID=32312811
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20052655A NO20052655L (no) | 2002-11-06 | 2005-06-02 | Sammensmeltede heterocykliske forbindelser |
Country Status (16)
Country | Link |
---|---|
US (2) | US7253179B2 (no) |
EP (1) | EP1562943A1 (no) |
JP (1) | JP4547266B2 (no) |
KR (1) | KR20050103184A (no) |
CN (2) | CN1330651C (no) |
AU (1) | AU2003285160B2 (no) |
BR (1) | BR0316070A (no) |
CA (1) | CA2505372A1 (no) |
EA (1) | EA009421B1 (no) |
IS (1) | IS7833A (no) |
MX (1) | MXPA05004739A (no) |
NO (1) | NO20052655L (no) |
NZ (1) | NZ540328A (no) |
PL (1) | PL376659A1 (no) |
WO (1) | WO2004043958A1 (no) |
ZA (1) | ZA200503654B (no) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070135425A1 (en) * | 2001-05-04 | 2007-06-14 | Amgen Inc. | Fused heterocyclic compounds |
US6809104B2 (en) | 2001-05-04 | 2004-10-26 | Tularik Inc. | Fused heterocyclic compounds |
EA009421B1 (ru) * | 2002-11-06 | 2007-12-28 | Эмджен Инк. | Конденсированные гетероциклические соединения |
JPWO2004069798A1 (ja) | 2003-02-10 | 2006-05-25 | 萬有製薬株式会社 | ピペリジン誘導体を有効成分とするメラニン凝集ホルモン受容体拮抗剤 |
DE102010025663A1 (de) * | 2010-06-30 | 2012-01-05 | Karl-Heinz Glüsenkamp | Neue beta-Aminoaldehyd-Derivate, Verfahren zu ihrer Herstellung und ihre chemische Verwendung als reaktive Intermediate |
JP2013538800A (ja) | 2010-08-10 | 2013-10-17 | アッヴィ・インコーポレイテッド | 新規trpv3モジュレーター |
US9012651B2 (en) | 2011-03-24 | 2015-04-21 | Abbvie Inc. | TRPV3 modulators |
EP2771322A2 (en) | 2011-10-24 | 2014-09-03 | AbbVie Inc. | Novel trpv3 modulators |
CN106588812B (zh) * | 2016-12-07 | 2019-02-22 | 烟台大学 | 一种酰氯制备2,4-二取代噻唑啉类化合物的方法 |
EP3911631A4 (en) * | 2019-01-14 | 2022-09-28 | Cadila Healthcare Limited | NEW SUBSTITUTED SULFONYLUREA DERIVATIVES |
HUP2200222A1 (hu) | 2022-06-17 | 2023-12-28 | Richter Gedeon Nyrt | MCHR1 antagonisták a Prader-Willi szindróma kezelésére |
Family Cites Families (55)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US23085A (en) * | 1859-03-01 | chandler | ||
US176694A (en) * | 1876-04-25 | Improvement in screw-cutting die-stocks | ||
US199549A (en) * | 1878-01-22 | Improvement in screw-propellers | ||
JPS5825980B2 (ja) | 1976-02-12 | 1983-05-31 | ヤマサ醤油株式会社 | サイクリックヌクレオチドの定量法 |
EP0257701A1 (en) | 1986-08-15 | 1988-03-02 | Cedona Pharmaceuticals B.V. | A process for preparing hydroxyl derivatives of compounds containing a carbazole, dibenzofurane or dibenzothiophene group |
US5049655A (en) | 1989-03-22 | 1991-09-17 | The Salk Institute For Biological Studies | Melanin-concentrating hormones |
JP2906654B2 (ja) | 1989-11-28 | 1999-06-21 | 東レ株式会社 | 免疫抑制剤及びその製造方法 |
US5401629A (en) | 1990-08-07 | 1995-03-28 | The Salk Institute Biotechnology/Industrial Associates, Inc. | Assay methods and compositions useful for measuring the transduction of an intracellular signal |
JP3160941B2 (ja) * | 1991-06-17 | 2001-04-25 | 東レ株式会社 | カルバゾール誘導体および免疫抑制剤 |
WO1993001186A1 (en) | 1991-07-05 | 1993-01-21 | Smithkline Beecham Farmaceutici S.P.A. | Hydroisoquinoline derivatives |
CA2124455C (en) | 1992-09-29 | 2004-09-14 | Hiroshi Nagase | Indole derivatives, process for producing the same and medicinal uses of the same |
US5272146A (en) | 1992-10-02 | 1993-12-21 | The United States Of America As Represented By The United States Department Of Health And Human Services | 1,2-dihydroellipticines with activity against CNS specific cancer cell lines |
US5457208A (en) | 1993-06-21 | 1995-10-10 | Regents Of The University Of Minnesota | Kappa opioid receptor antagonists |
US5464841A (en) | 1993-11-08 | 1995-11-07 | Univ Minnesota | Use of delta opioid receptor antagonists to treat immunoregulatory disorders |
US5578725A (en) | 1995-01-30 | 1996-11-26 | Regents Of The University Of Minnesota | Delta opioid receptor antagonists |
US5849708A (en) | 1995-06-06 | 1998-12-15 | Joslin Diabetes Center, Inc. | Promotion of eating behavior |
EP0848060A3 (en) | 1996-12-11 | 2000-02-02 | Smithkline Beecham Corporation | Novel human 11CB splice variant |
AU739367B2 (en) | 1997-01-16 | 2001-10-11 | Toray Industries, Inc. | Indolomorphinan derivative and agent for curing and preventing cerebral disorder |
US6555339B1 (en) | 1997-04-14 | 2003-04-29 | Arena Pharmaceuticals, Inc. | Non-endogenous, constitutively activated human protein-coupled receptors |
WO1999028492A1 (en) | 1997-12-03 | 1999-06-10 | Smithkline Beecham Corporation | A method of finding agonist and antagonist to human 11cb splice variant |
AU742425B2 (en) | 1998-06-11 | 2002-01-03 | Merck & Co., Inc. | Spiropiperidine derivatives as melanocortin receptor agonists |
CA2342833A1 (en) | 1998-09-17 | 2000-03-23 | Incyte Pharmaceuticals, Inc. | Human gpcr proteins |
GB9822158D0 (en) | 1998-10-09 | 1998-12-02 | Nycomed Imaging As | Compositions |
DE69935159T2 (de) | 1998-12-28 | 2007-10-25 | Takeda Pharmaceutical Co. Ltd. | Screening-verfahren |
US6221613B1 (en) | 1998-12-31 | 2001-04-24 | Synaptic Pharmaceutical Corporation | DNA encoding a human melanin concentrating hormone receptor (MCH1) and uses thereof |
WO2000049170A1 (en) | 1999-02-18 | 2000-08-24 | Smithkline Beecham Corporation | MURINE 11cby RECEPTOR |
WO2000049046A1 (fr) | 1999-02-19 | 2000-08-24 | Takeda Chemical Industries, Ltd. | Nouvelle proteine de recepteur couplee a la proteine g et adn |
CA2372980A1 (en) | 1999-05-19 | 2000-11-23 | Astrazeneca Ab | Assays for agonists, agonists and inverse agonists of melanin concentrating hormone (mch) binding to the somatostatin-like receptor (slc-1) |
AU5869100A (en) | 1999-06-08 | 2000-12-28 | Regents Of The University Of California, The | Melanin concentrating hormone receptor |
US7198910B1 (en) | 1999-07-14 | 2007-04-03 | Merck & Co., Inc. | Nucleic acid encoding melanin-concentrating hormone receptor |
JP2003505082A (ja) | 1999-07-26 | 2003-02-12 | ジェネンテック・インコーポレーテッド | 新規なポリヌクレオチドとその使用法 |
EP1196572A1 (en) | 1999-07-27 | 2002-04-17 | Smithkline Beecham Plc | Axor21, a g-protein coupled receptor |
AU7315800A (en) | 1999-09-20 | 2001-04-24 | Takeda Chemical Industries Ltd. | Mch antagonists |
AU7315700A (en) | 1999-09-20 | 2001-04-24 | Takeda Chemical Industries Ltd. | Melanin concentrating hormone antagonist |
CA2392090A1 (en) | 1999-11-16 | 2001-05-25 | Merck & Co., Inc. | G-protein coupled receptor |
JP2001226269A (ja) | 2000-02-18 | 2001-08-21 | Takeda Chem Ind Ltd | メラニン凝集ホルモン拮抗剤 |
EP1265926A1 (en) | 2000-03-15 | 2002-12-18 | Merck & Co., Inc. | Melanin concentrating hormone receptor chimeric and fusion proteins |
JP2005229804A (ja) | 2000-03-24 | 2005-09-02 | Astellas Pharma Inc | 新規なメラニンコンセントレーティングホルモン受容体 |
US7229986B2 (en) | 2000-05-16 | 2007-06-12 | Takeda Pharmaceutical Company Ltd. | Melanin-concentrating hormone antagonist |
AU783403B2 (en) | 2000-07-05 | 2005-10-20 | H. Lundbeck A/S | Selective melanin concentrating hormone-1 (MCH1) receptor antagonists and uses thereof |
WO2002003070A1 (fr) | 2000-07-05 | 2002-01-10 | Takeda Chemical Industries, Ltd. | Procede de criblage d'antagoniste/agoniste du recepteur de l'hormone de concentration de la melanine (mch) |
CA2384358A1 (en) | 2000-07-05 | 2002-01-10 | Synaptic Pharmaceutical Corporation | Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof |
AU2001279294A1 (en) * | 2000-07-06 | 2002-01-21 | Neurogen Corporation | Melanin concentrating hormone receptor ligands |
IL154911A0 (en) | 2000-10-20 | 2003-10-31 | Pfizer Prod Inc | Alpha-aryl ethanolamines and their use as beta-3 adrenergic receptor agonists |
US20030022891A1 (en) | 2000-12-01 | 2003-01-30 | Anandan Palani | MCH antagonists and their use in the treatment of obesity |
WO2002051809A1 (en) * | 2000-12-22 | 2002-07-04 | Schering Corporation | Piperidine mch antagonists and their use in the treatment of obesity |
US6900329B2 (en) | 2001-03-21 | 2005-05-31 | Schering Corporation | MCH antagonists and their use in the treatment of obesity |
HUP0400252A3 (en) | 2001-03-21 | 2011-09-28 | Pharmacopeia Drug Discovery | Aryl and biaryl compounds having mch modulatory activity, pharmaceutical compositions containing them and process for producing them |
AR035234A1 (es) * | 2001-04-12 | 2004-05-05 | Pharmacopeia Drug Discovery | Aril y biaril-piperidinas con actividad moduladora mch, metodo para preparar dichos compuestos, composiciones farmaceuticas, metodo para preparar las composiciones farmaceuticas y el uso de dichos compuestos para la manufactura de un medicamento |
JP2004529161A (ja) * | 2001-05-04 | 2004-09-24 | トゥラリック インコーポレイテッド | 縮合複素環式化合物 |
US6809104B2 (en) | 2001-05-04 | 2004-10-26 | Tularik Inc. | Fused heterocyclic compounds |
EP1389189A2 (en) | 2001-05-22 | 2004-02-18 | Neurogen Corporation | Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues |
CA2467857C (en) * | 2001-11-26 | 2010-08-24 | Duane A. Burnett | Piperidine-based mch antagonists for treatment of obesity and cns disorders |
EP1465635A4 (en) | 2002-01-10 | 2005-04-13 | Neurogen Corp | MELANIN-CONCENTRATING HORMONIC RECEPTOR LIGANDS: SUBSTITUTED 2- (4-BENZYL-PIPERAZIN-1-YLMETHYL) AND 2- (4-BENZYL-DIAZEPAN-1-YLMETHYL) -1H-BENZOIMIDAZOLE ANALOGUES |
EA009421B1 (ru) | 2002-11-06 | 2007-12-28 | Эмджен Инк. | Конденсированные гетероциклические соединения |
-
2003
- 2003-11-06 EA EA200500770A patent/EA009421B1/ru not_active IP Right Cessation
- 2003-11-06 AU AU2003285160A patent/AU2003285160B2/en not_active Ceased
- 2003-11-06 NZ NZ540328A patent/NZ540328A/en unknown
- 2003-11-06 PL PL376659A patent/PL376659A1/pl not_active Application Discontinuation
- 2003-11-06 ZA ZA200503654A patent/ZA200503654B/en unknown
- 2003-11-06 BR BR0316070-0A patent/BR0316070A/pt not_active IP Right Cessation
- 2003-11-06 CN CNB2003801082225A patent/CN1330651C/zh not_active Expired - Fee Related
- 2003-11-06 MX MXPA05004739A patent/MXPA05004739A/es active IP Right Grant
- 2003-11-06 US US10/705,173 patent/US7253179B2/en not_active Expired - Fee Related
- 2003-11-06 EP EP03779483A patent/EP1562943A1/en not_active Withdrawn
- 2003-11-06 WO PCT/US2003/035543 patent/WO2004043958A1/en active Application Filing
- 2003-11-06 KR KR1020057008174A patent/KR20050103184A/ko not_active Application Discontinuation
- 2003-11-06 CN CNA2007101119484A patent/CN101134757A/zh active Pending
- 2003-11-06 CA CA002505372A patent/CA2505372A1/en not_active Abandoned
- 2003-11-06 JP JP2004551872A patent/JP4547266B2/ja not_active Expired - Fee Related
-
2005
- 2005-05-02 IS IS7833A patent/IS7833A/is unknown
- 2005-06-02 NO NO20052655A patent/NO20052655L/no not_active Application Discontinuation
-
2007
- 2007-07-26 US US11/881,805 patent/US20080058365A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
IS7833A (is) | 2005-05-02 |
CA2505372A1 (en) | 2004-05-27 |
US7253179B2 (en) | 2007-08-07 |
EP1562943A1 (en) | 2005-08-17 |
ZA200503654B (en) | 2006-09-27 |
NZ540328A (en) | 2008-02-29 |
KR20050103184A (ko) | 2005-10-27 |
EA200500770A1 (ru) | 2005-12-29 |
US20080058365A1 (en) | 2008-03-06 |
CN1735613A (zh) | 2006-02-15 |
CN1330651C (zh) | 2007-08-08 |
US20040147538A1 (en) | 2004-07-29 |
EA009421B1 (ru) | 2007-12-28 |
JP2006508130A (ja) | 2006-03-09 |
MXPA05004739A (es) | 2005-08-02 |
BR0316070A (pt) | 2005-09-27 |
AU2003285160B2 (en) | 2009-06-04 |
AU2003285160A1 (en) | 2004-06-03 |
WO2004043958A1 (en) | 2004-05-27 |
PL376659A1 (pl) | 2006-01-09 |
JP4547266B2 (ja) | 2010-09-22 |
NO20052655L (no) | 2005-07-26 |
CN101134757A (zh) | 2008-03-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IS8348A (is) | Samrunnin heteróhringasambönd | |
IS7471A (is) | Ný efnasambönd | |
IS7879A (is) | Ný efnasambönd | |
ATE478870T1 (de) | Spiroindolinpiperidinderivate | |
ATE460418T1 (de) | Heterocyclocarboxamidderivate | |
DE60330372D1 (de) | Indol-3-schwefelderivate | |
ATE467631T1 (de) | Chinuclidinamidderivate | |
ATE368042T1 (de) | Cephemverbindungen | |
IS7720A (is) | Píperidín-N-oxíð-afleiður | |
DK1490355T3 (da) | Indolylmaleimidderivater | |
ATE438644T1 (de) | Chinazolinderivate | |
DK2248807T3 (da) | N-Phenyl-2-pyrimidinaminderivater | |
NO20052655D0 (no) | Sammensmeltede heterocykliske forbindelser | |
IS7827A (is) | Ný efnasambönd | |
IS7381A (is) | Efnasambönd | |
DE602004019555D1 (de) | Heterocyclische 7-aminoalkylidenylchinolone und -naphthyridone | |
IS7414A (is) | Oxó-azabísýklísk efnasambönd | |
DE60307512D1 (de) | 3h-chinazoline -4-on derivaten | |
NO20045659L (no) | Forbindelser | |
ATE423771T1 (de) | Tetrahydrochinolinderivate | |
ATE496887T1 (de) | Substituierte 5-aminomethyl-1h-pyrrol-2-carbons ureamide | |
DE602004007387D1 (de) | 5-substituierte chinazolinonderivate | |
NO20023047D0 (no) | Kompenseringsanordning | |
DE50306277D1 (de) | 4-alkyl-/4-alkenyl-/4-alkinylmethyl/-1-arylcyclohexylamin-derivate | |
IS7906A (is) | Afleiður própargýl-tríflúorómetoxý-amínó-benzóþíazóls |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |